| 8401 |
Apheresis |
Autologous |
Neuroblastoma |
Hematology |
2013 |
Standard Therapy |
Germany |
1 |
| 8402 |
Apheresis |
Allogeneic |
No Data |
Hematology |
2013 |
Standard Therapy |
Germany |
51 |
| 8403 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2013 |
Standard Therapy |
Germany |
60 |
| 8404 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2013 |
Standard Therapy |
Germany |
60 |
| 8405 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2013 |
Standard Therapy |
Germany |
60 |
| 8406 |
Apheresis |
Autologous |
Non-Hodgkin-Lymphoma-Relapse |
Hematology |
2013 |
Standard Therapy |
Germany |
68 |
| 8407 |
Apheresis |
Autologous |
Non-Hodgkin-Lymphoma-Relapse |
Hematology |
2013 |
Standard Therapy |
Germany |
73 |
| 8408 |
Apheresis |
Autologous |
Plasmacytoma |
Hematology |
2013 |
Standard Therapy |
Germany |
62 |
| 8409 |
Apheresis |
Allogeneic |
Primary Central Nervous System Lymphoma |
Hematology |
2013 |
Standard Therapy |
Germany |
52 |
| 8410 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2013 |
Standard Therapy |
Germany |
43 |
| 8411 |
Apheresis |
Allogeneic |
Primary Myelofibrosis, Second Acute Myeloid Leukemia |
Hematology |
2013 |
Standard Therapy |
Germany |
60 |
| 8412 |
Apheresis |
Allogeneic |
Primary Osteomyelofibrosis |
Hematology |
2013 |
Standard Therapy |
Germany |
59 |
| 8413 |
Apheresis |
Allogeneic |
T-Cell Acute Myeloid Leukemia |
Hematology |
2013 |
Standard Therapy |
Germany |
61 |
| 8414 |
Apheresis |
Allogeneic |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2013 |
Standard Therapy |
Germany |
45 |
| 8415 |
Apheresis |
Autologous |
Teratocarcinoma |
Hematology |
2013 |
Standard Therapy |
Germany |
49 |
| 8416 |
Apheresis |
Autologous |
Testicular Cancer Relapse |
Hematology |
2013 |
Standard Therapy |
Germany |
27 |
| 8417 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2012 |
Experimental Therapy |
Poland |
19,7 |
| 8418 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2012 |
Experimental Therapy |
Poland |
7,1 |
| 8419 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2012 |
Experimental Therapy |
Poland |
4,3 |
| 8420 |
Cord Blood |
Allogeneic – Related |
Acute Lymphoblastic Leukemia |
Hematology |
2012 |
Standard Therapy |
Germany |
2 |
| 8421 |
Cord Blood |
Allogeneic – Related |
Beta Thalassemia |
Hematology |
2012 |
Standard Therapy |
Germany |
14 |
| 8422 |
Cord Blood |
Autologous |
Brain Damage |
Neurology |
2012 |
Experimental Therapy |
Germany |
3 |
| 8423 |
Cord Blood |
Autologous |
Cerebral Palsy |
Neurology |
2012 |
Experimental Therapy |
Portugal |
3 |
| 8424 |
Cord Blood |
Allogeneic – Related |
Myelodysplastic Syndrome |
Hematology |
2012 |
Standard Therapy |
Hungary |
3 |
| 8425 |
Cord Blood |
Allogeneic – Related |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2012 |
Standard Therapy |
Turkey |
4,1 |
| 8426 |
Cord Blood |
Allogeneic – Related |
Thalassemia Major |
Hematology |
2012 |
Standard Therapy |
Turkey |
6,7 |
| 8427 |
Cord Blood |
Allogeneic – Related |
Thalassemia Major, Acute Lymphoblastic Leukemia |
Hematology |
2012 |
Standard Therapy |
Turkey |
3,6 |
| 8428 |
Cord Blood |
Autologous |
Typ-1-Diabetes |
Endocrinology |
2012 |
Experimental Therapy |
Germany |
5 |
| 8429 |
Bone Marrow |
Autologous |
Ischemic Myopathy |
Hematology |
2012 |
Standard Therapy |
Germany |
64 |
| 8430 |
Bone Marrow |
Autologous |
Ischemic Myopathy |
Hematology |
2012 |
Standard Therapy |
Germany |
75 |
| 8431 |
Bone Marrow |
Autologous |
Ischemic Myopathy |
Hematology |
2012 |
Standard Therapy |
Germany |
55 |
| 8432 |
Bone Marrow |
Autologous |
Ischemic Myopathy |
Hematology |
2012 |
Standard Therapy |
Germany |
56 |
| 8433 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome Refractory Anemia With Blast Excess |
Hematology |
2012 |
Standard Therapy |
Germany |
70 |
| 8434 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2012 |
Standard Therapy |
Germany |
18 |
| 8435 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2012 |
Standard Therapy |
Germany |
42 |
| 8436 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2012 |
Standard Therapy |
Germany |
43 |
| 8437 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2012 |
Standard Therapy |
Germany |
60 |
| 8438 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2012 |
Standard Therapy |
Germany |
39 |
| 8439 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2012 |
Standard Therapy |
Germany |
62 |
| 8440 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2012 |
Standard Therapy |
Germany |
55 |
| 8441 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2012 |
Standard Therapy |
Germany |
17 |
| 8442 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia – Relapse |
Hematology |
2012 |
Standard Therapy |
Germany |
48 |
| 8443 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia – Relapse |
Hematology |
2012 |
Standard Therapy |
Germany |
46 |
| 8444 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia – Relapse |
Hematology |
2012 |
Standard Therapy |
Germany |
68 |
| 8445 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia (High Risk) |
Hematology |
2012 |
Standard Therapy |
Germany |
57 |
| 8446 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2012 |
Standard Therapy |
Germany |
47 |
| 8447 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2012 |
Standard Therapy |
Germany |
43 |
| 8448 |
Apheresis |
Autologous |
B-Cell Non-Hodgkin Lymphoma – Relapse |
Hematology |
2012 |
Standard Therapy |
Germany |
70 |
| 8449 |
Apheresis |
Autologous |
Central Nervous System Non-Hodgkin Lymphoma |
Hematology |
2012 |
Standard Therapy |
Germany |
54 |
| 8450 |
Apheresis |
Autologous |
Cerebral Diffuse Large B-Cell Lymphoma-Relapse |
Hematology |
2012 |
Standard Therapy |
Germany |
55 |
| 8451 |
Apheresis |
Autologous |
Diffuse Large B-Cell Non-Hodgkin-Lymphoma |
Hematology |
2012 |
Standard Therapy |
Germany |
54 |
| 8452 |
Apheresis |
Autologous |
Extragonadal Germ Cell Tumor |
Hematology |
2012 |
Standard Therapy |
Germany |
59 |
| 8453 |
Apheresis |
Autologous |
Follicular Lymphoma |
Hematology |
2012 |
Standard Therapy |
Germany |
54 |
| 8454 |
Apheresis |
Autologous |
Follicular Lymphoma |
Hematology |
2012 |
Standard Therapy |
Germany |
57 |
| 8455 |
Apheresis |
Autologous |
Follicular Lymphoma-Relapse |
Hematology |
2012 |
Standard Therapy |
Germany |
59 |
| 8456 |
Apheresis |
Autologous |
Lymphoblastic B-Cell Non-Hodgkin-Lymphoma |
Hematology |
2012 |
Standard Therapy |
Germany |
52 |
| 8457 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2012 |
Standard Therapy |
Germany |
61 |
| 8458 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2012 |
Standard Therapy |
Germany |
52 |
| 8459 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2012 |
Standard Therapy |
Germany |
57 |
| 8460 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2012 |
Standard Therapy |
Germany |
55 |
| 8461 |
Apheresis |
Autologous |
Medulloblastoma |
Hematology |
2012 |
Standard Therapy |
Germany |
42 |
| 8462 |
Apheresis |
Autologous |
Morbus Hodgkin-Relapse |
Hematology |
2012 |
Standard Therapy |
Germany |
27 |
| 8463 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2012 |
Standard Therapy |
Germany |
51 |
| 8464 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2012 |
Standard Therapy |
Germany |
60 |
| 8465 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2012 |
Standard Therapy |
Germany |
52 |
| 8466 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2012 |
Standard Therapy |
Germany |
71 |
| 8467 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2012 |
Standard Therapy |
Germany |
61 |
| 8468 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2012 |
Standard Therapy |
Germany |
53 |
| 8469 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2012 |
Standard Therapy |
Germany |
55 |
| 8470 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2012 |
Standard Therapy |
Germany |
70 |
| 8471 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2012 |
Standard Therapy |
Germany |
46 |
| 8472 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2012 |
Standard Therapy |
Germany |
64 |
| 8473 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2012 |
Standard Therapy |
Germany |
56 |
| 8474 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2012 |
Standard Therapy |
Germany |
68 |
| 8475 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2012 |
Standard Therapy |
Germany |
48 |
| 8476 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2012 |
Standard Therapy |
Germany |
59 |
| 8477 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2012 |
Standard Therapy |
Germany |
62 |
| 8478 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2012 |
Standard Therapy |
Germany |
72 |
| 8479 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2012 |
Standard Therapy |
Germany |
50 |
| 8480 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2012 |
Standard Therapy |
Germany |
60 |
| 8481 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2012 |
Standard Therapy |
Germany |
65 |
| 8482 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2012 |
Standard Therapy |
Germany |
67 |
| 8483 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2012 |
Standard Therapy |
Germany |
49 |
| 8484 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2012 |
Standard Therapy |
Germany |
69 |
| 8485 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2012 |
Standard Therapy |
Germany |
62 |
| 8486 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2012 |
Standard Therapy |
Germany |
57 |
| 8487 |
Apheresis |
Autologous |
Non-Hodgkin-Lymphoma-Relapse |
Hematology |
2012 |
Standard Therapy |
Germany |
62 |
| 8488 |
Apheresis |
Autologous |
Non-Hodgkin-Lymphoma-Relapse |
Hematology |
2012 |
Standard Therapy |
Germany |
57 |
| 8489 |
Apheresis |
Autologous |
Non-Hodgkin-Lymphoma-Relapse |
Hematology |
2012 |
Standard Therapy |
Germany |
44 |
| 8490 |
Apheresis |
Autologous |
Non-Hodgkin-Lymphoma-Relapse |
Hematology |
2012 |
Standard Therapy |
Germany |
43 |
| 8491 |
Apheresis |
Allogeneic |
Osteomyelofibrosis |
Hematology |
2012 |
Standard Therapy |
Germany |
61 |
| 8492 |
Apheresis |
Autologous |
Plasmablastic Lymphoma |
Hematology |
2012 |
Standard Therapy |
Germany |
54 |
| 8493 |
Apheresis |
Autologous |
Plasmacytoma |
Hematology |
2012 |
Standard Therapy |
Germany |
69 |
| 8494 |
Apheresis |
Autologous |
Testicular Cancer Relapse |
Hematology |
2012 |
Standard Therapy |
Germany |
36 |
| 8495 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2011 |
Experimental Therapy |
Poland |
17,2 |
| 8496 |
Cord Blood |
Allogeneic – Related |
Acute Lymphoblastic Leukemia |
Hematology |
2011 |
Standard Therapy |
Poland |
5 |
| 8497 |
Cord Blood |
Allogeneic – Related |
Acute Lymphoblastic Leukemia |
Hematology |
2011 |
Standard Therapy |
UK |
8 |
| 8498 |
Cord Blood |
Allogeneic – Related |
Acute Myeloid Leukemia |
Hematology |
2011 |
Standard Therapy |
Hungary |
2 |
| 8499 |
Cord Blood |
Autologous |
Brain Damage |
Neurology |
2011 |
Experimental Therapy |
Germany |
3 |
| 8500 |
Cord Blood |
Autologous |
Brain Damage |
Neurology |
2011 |
Experimental Therapy |
Germany |
7 |